vimarsana.com

Latest Breaking News On - Hedge funds weigh in on vanda pharmaceuticals - Page 1 : vimarsana.com

Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Short Interest Down 16 9% in April

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 2,070,000 shares, a drop of 16.9% from the March 31st total of 2,490,000 shares. Based on an average daily trading volume, of 2,290,000 shares, the days-to-cover […]

Vanda Pharmaceuticals Inc (NASDAQ:VNDA) Short Interest Update

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) was the target of a large decline in short interest in September. As of September 30th, there was short interest totalling 1,510,000 shares, a decline of 64.1% from the September 15th total of 4,210,000 shares. Currently, 3.1% of the company’s stock are short sold. Based on an […]

Vanda Pharmaceuticals (NASDAQ:VNDA) Earns Buy Rating from Analysts at StockNews com

StockNews.com initiated coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research note issued to investors on Thursday. The firm issued a buy rating on the biopharmaceutical company’s stock. Vanda Pharmaceuticals Trading Up 0.2 % NASDAQ:VNDA opened at $5.85 on Thursday. Vanda Pharmaceuticals has a 1 year low of $5.45 and a […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.